| CTRI Number |
CTRI/2024/10/075181 [Registered on: 14/10/2024] Trial Registered Prospectively |
| Last Modified On: |
11/10/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
|
Public Title of Study
|
To study the correlation between preoperative pregabalin premedication and its perioperative opioid sparing effects in brain tumour patients undergoing craniotomies. |
|
Scientific Title of Study
|
Effects of pregabalin on perioperative opioid-sparing effects on patients
undergoing craniotomies for brain tumors. A Randomized, double-blinded, placebo
controlled study. |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Sai Saravanan K |
| Designation |
Post Graduate - Junior Resident |
| Affiliation |
AIIMS, RAIPUR |
| Address |
Department of Anaesthesiology, AIIMS Raipur
Raipur
CHHATTISGARH
India
Raipur CHHATTISGARH 492099 India |
| Phone |
9597140794 |
| Fax |
|
| Email |
saikicha98@yahoo.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Monica Malhotra |
| Designation |
Professor |
| Affiliation |
AIIMS, RAIPUR |
| Address |
Department of Anaesthesiology, AIIMS Raipur
Raipur
CHHATTISGARH
India
Raipur CHHATTISGARH 492099 India |
| Phone |
8518881714 |
| Fax |
|
| Email |
monicakhetrapal@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Monica Malhotra |
| Designation |
Professor |
| Affiliation |
AIIMS, RAIPUR |
| Address |
Department of Anaesthesiology, AIIMS Raipur
Raipur
CHHATTISGARH
India
Raipur CHHATTISGARH 492099 India |
| Phone |
8518881714 |
| Fax |
|
| Email |
monicakhetrapal@yahoo.com |
|
|
Source of Monetary or Material Support
|
| All India Institute of Medical Sciences,
Tatibandh,GE Road ,Raipur
Chattisgarh 492099
INDIA |
|
|
Primary Sponsor
|
| Name |
Nil |
| Address |
nil |
| Type of Sponsor |
Other [Nil] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Sai Saravanan K |
AIIMS, RAIPUR |
Department of Anaesthesiology, Neurosurgery OT,
Superspeciality OT Complex
4th Floor, B block
Raipur CHHATTISGARH |
9597140794
saikicha98@yahoo.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institute Ethics Committee, AIIMS Raipur |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: D332||Benign neoplasm of brain, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
placebo/vitamin capsules |
Given on night before and morning 2 hours before surgery with sips of water |
| Intervention |
Pregabalin |
150 mg each Given on night before and morning 2 hours before surgery with sips of water |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1) Patients of either gender
2) Age 18–65 years
3) ASA class I, II
4) Patients with GCS 15
5) Scheduled for elective craniotomies for excision of brain tumors |
|
| ExclusionCriteria |
| Details |
1)Allergy to study drugs and opioid dependence.
2)Patients undergoing emergency surgery.
3)Patients receiving chronic neuroleptics, tricyclic antidepressants, serotonin noradrenaline
reuptake inhibitors |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
a]Total intra-operative opioid consumption
b] Post-operative pain scores and rescue analgesia. |
a]Till 12 hours postoperative
b]Till 12 hours postoperative |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
a] Incidence of adverse effects of opioids like PONV, shivering.
b] Incidence of emergence delirium and delayed recovery. |
a]Till 12 hours postoperative |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
22/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
• A craniotomy is a neurosurgical procedure done to get a wide cranial opening for doing surgical therapeutic maneuvers. Posi-craniotomy pain is a common entity. Pain can elicit a complex set of neural, and cardiac. and respiratory changes, leading to increased cerebral blood flow and intracranial pressure, cerebral edema, and even intracranial bleeding operative analgesics. Traditionally, opioids are being used in craniotomy cases for induction, intraoperative pain management, and post• operative pain management. Opioids are potent analgesics but their usage can interfere with neurological monitoring and are associated with serious side effects like PONV, constipation, pruritis, sedation, opioid-induced hyperalgesia (OIH), and life-threatening respiratory depression. Pregabalin has been evaluated for postoperative analgesia in orthopedic and spine surgeries, laparoscopic hysterectomy, laparoscopic cholecystectomy, and thoracotomy, etc., Preemptive use of gabapentinoids is also known to effectively reduce opioid consumption There is a deficiency of trials investigating its effects in attenuating perioperative pain in intracranial surgeries. This study was designed to evaluate the opioid-sparing effect of preoperative pregabalin in patients undergoing craniotomy for brain tumors Studies of pregabalin in neurosurgical patients are scarce. There are only a few published randomized studies of pregabalin use for analgesia in patients undergoing craniotomy and these limited studies compare pre-emptive pregabalin and gabapentin and their opioid-sparing effects. However, these studies have some drawbacks like using sub-therapeutic doses of pregabalin, non-consideration of opioid side effects, and prolonged postoperative use of pregabalin, which we would like to correct in our study. |